Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Establishment and Characterization of a CD20-Positive NK/T-Cell Lymphoma Cell Line.

Clinical laboratory - 1 Jan 2015

Gu Linhui, Hong Lianlian, Ling Zhiqiang, Feng Jianguo, Zheng Zhiguo, Du Lingbin, Mou Hanzhou, Sun Wenyong, Kong Xiangming, Ling Yutian, Jiang Zhiming, Zhu Chihong, Mao Weimin, Qian Lijuan

Abstract excerpt

BACKGROUND: CD20 positive NK/T-cell lymphoma is extremely rare and difficult for clinical treatment. Due to the lack of an established cell model for this disease, less is known about its biological characterization and potential therapeutic options. METHODS: A cell line of NK/T-cell lymphoma, wh...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD20
Share to Cell Shape
Share to Comparative Genomic Hybridization

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor

Share to Genes, Immunoglobulin Heavy Chain

Share to Herpesvirus 4, Human

Share to Immunomagnetic Separation

Share to Nose Neoplasms

Source

Identifiers

PMID: 26299072
DOI: 10.7754/clin.lab.2014.140602

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-26299072-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Establishment and Characterization of a CD20-Positive NK/T-Cell Lymphoma Cell Line.PMID 26299072Read ↗

Establishment and comprehensive analysis of a new human cell line (NK-NJ) with NK-cell characteristics established from extranodal natural killer cell lymphoma/leukemia.Semantic proximity Read ↗

Natural Killer/T-Cell Lymphoma in Children and Adolescents: Clinicopathologic and Gene Expression Profiling Study of 22 CasesSemantic proximity Read ↗

A retrospective study on the clinicopathological and molecular features of 22 cases of natural killer/T-cell lymphoma in children and adolescentsSemantic proximity Read ↗

Natural killer cell neoplasmsSemantic proximity Read ↗

Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosisSemantic proximity Read ↗

Natural killer cell malignancies: clinicopathologic and molecular features.Semantic proximity Read ↗

CD4- and CD56-positive T-cell line, MTA, established from natural killer-like T-cell leukemia/lymphoma.Semantic proximity Read ↗

Inhibition of CDK4 as a potential therapy for natural killer cell lymphoma with MYC overexpressionSemantic proximity Read ↗

Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells.Semantic proximity Read ↗

Establishment of an IL-2-dependent cell line derived from 'nasal-type' NK/T-cell lymphoma of CD2+, sCD3-, CD3epsilon+, CD56+ phenotype and associated with the Epstein-Barr virus.Semantic proximity Read ↗

The case of T-ALL presenting with NK phenotype after COVID-19 vaccination.Semantic proximity Read ↗

Immunomorphologic profile and Epstein-Barr virus status of a cohort of 35 cases of extranodal natural killer/T-cell lymphoma, nasal type of upper aerodigestive tract from a tertiary care center in South India.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.